Literature DB >> 6967923

Inhibition of cell mediated immune responses by 8-methoxypsoralen and long-wave ultraviolet light: a possible explanation for the clinical effects of photoactivated psoralen.

V B Morhenn, C J Benike, E G Engleman.   

Abstract

Human thymus-derived lymphocytes proliferate when cultured with lymphocyes or epidermal cells from unrelated individuals because such cells express HLA-D antigens, which are recognized as foreign by thymus-derived lymphocytes. The current study demonstrates that these responses are inhibited if either the stimulator cells or responder cells are pretreated with the combination of 8-methoxypsoralen and long-wave ultraviolet light. Additional studies revealed that photoactivated 8-methoxypsoralen has a lethal effect on lymphocytes and monocytes but not on the majority of epidermal cells. These obervations suggest that the dramatic beneficial effect of PUVA on patients with psoriasis and other skin disorders may be due to a toxic effect on immunocompetent cells in the epidermis, which results in inhibition of cell mediated immune responses.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6967923     DOI: 10.1111/1523-1747.ep12523271

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  4 in total

1.  Epidermal T lymphocytes and dendritic cells in chronic plaque psoriasis: the effects of PUVA treatment.

Authors:  B S Baker; A F Swain; C E Griffiths; J N Leonard; L Fry; H Valdimarsson
Journal:  Clin Exp Immunol       Date:  1985-09       Impact factor: 4.330

2.  The effect of 8-methoxypsoralen and longwave UV-radiation on growth rates of human epidermal cells in culture.

Authors:  M R West; M J Faed
Journal:  Experientia       Date:  1983-02-15

Review 3.  Risk of melanoma with psoralen/ultraviolet A therapy for psoriasis. Do the known risks now outweigh the benefits?

Authors:  B Lindelöf
Journal:  Drug Saf       Date:  1999-04       Impact factor: 5.606

Review 4.  Psoriasis. A review of recent advances in treatment.

Authors:  E M Farber; L Nall
Journal:  Drugs       Date:  1984-10       Impact factor: 9.546

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.